By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Gilead Sciences, Inc. (Durham, NC) 

4 University Place
4611 University Drive
Durham  North Carolina  27707  U.S.A.
Phone: 919-493-5980 or 800-GILEAD-5 (800-445-3235)
Fax: 919-493-5925


Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need.The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Headquartered in Foster City, California, Gilead has operations in North America, Europe and Australia.

Key Contacts:
John C. Martin, PhD, Chairman and Chief Executive Officer
John F. Milligan, PhD, President and Chief Operating Officer
Norbert W. Bischofberger, PhD, Executive Vice President, Research and Development and Chief Scientific Officer
Kevin Young, Executive Vice President, Commercial Operations
Kristen Metza, Senior Vice President, Human Resources
Susan Hubbard, Vice President, Investor Relations
Amy Flood, Senior Director, Public Affairs

Last Updated: 07-15-2008

Key Statistics

Ownership: Private

Web Site: Gilead (Durham, NC)
Employees: 3,200
Symbol: GILD


Company News
Gilead Sciences (Foster City, CA) (GILD) To Acquire Myogen (MYOG) For $2.5 Billion 10/2/2006 8:54:27 AM
India's JB Chemicals & Pharmaceuticals Limited To Make And Sell Gilead Sciences (Foster City, CA) (GILD) Drug 9/22/2006 8:45:44 AM
Gilead Sciences, Inc. (Durham, NC) (GILD) To Present At The Bear Stearns 19th Annual Healthcare Conference On Tuesday, September 12th; Webcast Available Through <>b>Gilead Corporate Website 9/11/2006 10:24:21 AM
Gilead Sciences (Foster City, CA) (GILD) Exercises Option To Acquire Corus Pharma, Inc. For $365 Million 8/3/2006 12:56:44 PM
Gilead Sciences (Foster City, CA) (GILD) Agrees To Exercise Its Option To Acquire Corus Pharma, Inc. For $365 Million 7/20/2006 10:37:03 AM
Gilead Sciences (Foster City, CA) (GILD) To Release Second Quarter 2006 Financial Results On Thursday, July 20, 2006 7/17/2006 4:30:43 PM
Gilead Sciences (Foster City, CA) (GILD) And The Institute Of Organic Chemistry And Biochemistry Establish New Academic Research Centre In Prague 7/13/2006 1:28:39 PM
FDA Approves Gilead Sciences (Foster City, CA) (GILD) And Bristol-Myers Squibb Company (BMY)'s ATRIPLA(TM), The First Once-Daily Single Tablet Regimen For Adults With HIV-1 Infection 7/13/2006 10:41:23 AM
All-In-One Pill For HIV 7/10/2006 1:57:34 PM
Gilead Sciences (Foster City, CA) (GILD) To Acquire Degussa's Raylo Chemicals Inc. For Approximately 115.2 Million Euros 6/6/2006 10:27:27 AM